SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899866-17-000163
Filing Date
2017-09-12
Accepted
2017-09-12 08:19:41
Documents
3
Period of Report
2017-09-12
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 2.06: Material Impairments
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8ksept122017.htm 8-K 26408
2 EXHIBIT 99.1 ex991_09122017.htm EX-99.1 37337
3 pr09122017image1.jpg GRAPHIC 26262
  Complete submission text file 0000899866-17-000163.txt   101198
Mailing Address 100 COLLEGE STREET NEW HAVEN CT 06510
Business Address 100 COLLEGE STREET NEW HAVEN CT 06510 2032722596
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 171080087
SIC: 2834 Pharmaceutical Preparations